Investment
Led CimCure's EUR5M seed round for tumor-vasculature-targeting cancer vaccine technology.
CimCure
Every public signal F4 has attached to this firm, with sources and cross-entity links.
CimCure
CellX Biosolutions
Ore Energy
CollimateHealth
Triple Bio
Carla Ostmann joined as Chief of Staff
Max Lebeau joined as Principal
Pasqal
Aevoloop
The Case for Betting on Radical Innovation
Positron PhD Fellowship launched